Hints and tips:
Related Special Reports
...German pharma group Boehringer Ingelheim and Copenhagen-based Zealand Pharma said their weight-loss drug had achieved positive results in liver disease trials....
...Boehringer Ingelheim is building a new manufacturing plant but, says Dias of the EMA, “you don’t build a new site overnight”....
...“We all agree that we need to rethink how this market works,” says Hubertus von Baumbach, head of German pharmaceutical group Boehringer Ingelheim, and chair of the European Federation of Pharmaceutical...
...of the pharmaceutical company Boehringer Ingelheim....
...Engelbert Coster Tjeenk Willink, a former executive at German pharma group Boehringer Ingelheim, will take the chief executive role on an interim basis, the board said....
...Hikma Pharmaceuticals was down 5.3 per cent to £22.31 after Citi analysts speculated about a possible bid for Roxane Laboratories, the $2.4bn-valued US generic drugmaker owned by Boehringer Ingelheim....
...But a so-called “biosimilar” developed by Eli Lilly and Boehringer Ingelheim was approved by European regulators last month and the pair are pushing for its entry into the US....
...“The partnership with Duke is very important to us,” says Kimberly Gacso, an executive director in charge of leadership development for Boehringer Ingelheim, the pharmaceuticals company, in the US....
...Unitaid is concentrating on putting into the pool 19 HIV medicines made by Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Pfizer, Roche and Tibotec, part of Johnson &...
...Analysts also saw over-the-counter medicines as a likely area of interest, with Evolution speculating that the drugs units of Germany’s Boehringer Ingelheim or Nycomed of Switzerland may appeal....
...Recent deals include the mandate to advise Kohlberg Kravis Roberts in its £955m acquisition of Pets at Home, and Boehringer Ingelheim, the German pharma group, in its acquisition of shares it did not already...
...While one of the drugs – Boehringer Ingelheim’s nevirapine – is widely donated by the company, a scarcity of clinics and health specialists in many developing countries limits its broader use....
...The biggest private family-owned company in Europe, according to rankings prepared by the Financial Times and McKinsey last year, is Boehringer Ingelheim, a pharmaceuticals group with an estimated equity...
...Ingelheim, Lonza Biologics and Reckitt Benckiser....
...Since it introduced tough new security measures in 2001, for example, Boehringer Ingelheim of Germany has identified more than 100 incidents of counterfeits of its products, which range from respiratory...
...Abbott had sold Boehringer Ingelheim’s blockbuster arthritis drug Mobic. U.S. pharmaceutical sales fell 21.9 percent....
...Boringer Boehringer Ingelheim, Germany's largest pharmaceuticals company, is boring, says boss Alessandro Banchi....
International Edition